Kerala Daily

Open Angle Glaucoma Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies – Santen, Bausch and Lomb, SPARC, Nicox ophthalmics, D.Western therapeutics

 Breaking News
  • No posts were found

Open Angle Glaucoma Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies – Santen, Bausch and Lomb, SPARC, Nicox ophthalmics, D.Western therapeutics

December 19
16:15 2022
Open Angle Glaucoma Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies - Santen, Bausch and Lomb, SPARC, Nicox ophthalmics, D.Western therapeutics
The Open Angle Glaucoma market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Open Angle Glaucoma pipeline products will significantly revolutionize the Open Angle Glaucoma market dynamics.

DelveInsight’s “Open Angle Glaucoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Open Angle Glaucoma, historical and forecasted epidemiology as well as the Open Angle Glaucoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Open Angle Glaucoma market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Open Angle Glaucoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Open Angle Glaucoma Market Insights

 

Open Angle Glaucoma Overview

Glaucoma is a disease that damages the eye’s optic nerve. It usually happens when fluid builds up in the front part of the eye. That extra fluid increases the pressure in eye, damaging the optic nerve. The condition is a leading cause of blindness for people over 60 years old. But blindness from glaucoma can often be prevented with early treatment

Some of the key facts of the Open Angle Glaucoma Market Report: 

  • The Open Angle Glaucoma market size was valued at USD 4,500 Million in the year 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • According to the American Academy of Ophthalmology, glaucoma describes a group of conditions in which there is characteristic cupping of the optic disc with corresponding visual field defects due to retinal ganglion cell loss
  • Total diagnosed prevalence of Glaucoma in 7MM was estimated to be ~11,048,000 cases in 2021 and is expected to increase during the study period (2019–2032)
  • Key Open Angle Glaucoma Companies: Santen, Bausch and Lomb, SPARC, Nicox ophthalmics, D.Western therapeutics, and others
  • Key Open Angle Glaucoma Therapies: DP-716, TC-002, Omidenepagisopropyl/DE-117, DE-130A, Sepetaprost (DE-126/ONO9054), and others
  • The Open Angle Glaucoma epidemiology based on gender analyzed that females are affected more with glaucoma than male

Get a Free sample for the Open Angle Glaucoma Market Report- 

https://www.delveinsight.com/sample-request/open-angle-glaucoma-market

Key benefits of the Open Angle Glaucoma Market report:

  1. Open Angle Glaucoma market report covers a descriptive overview and comprehensive insight of the Open Angle Glaucoma Epidemiology and Open Angle Glaucoma market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Open Angle Glaucoma market report provides insights on the current and emerging therapies.
  3. Open Angle Glaucoma market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Open Angle Glaucoma market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Open Angle Glaucoma market.

Download the report to understand which factors are driving Open Angle Glaucoma epidemiology trends @ Open Angle Glaucoma Epidemiological Insights 

Open Angle Glaucoma Market  

The dynamics of the Open Angle Glaucoma market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“The mainstay of the treatment for Open Angle Glaucoma is to improve quality of life. There are therapies that are undergoing investigational analysis for the same. Pharmaceutical giants like Santen, SPARC, Bausch and Lomb, and others have their candidates in the pipeline.”

Open Angle Glaucoma Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Open Angle Glaucoma Epidemiology Segmentation:

The Open Angle Glaucoma market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Open Angle Glaucoma
  • Prevalent Cases of Open Angle Glaucoma by severity
  • Gender-specific Prevalence of Open Angle Glaucoma
  • Diagnosed Cases of Episodic and Chronic Open Angle Glaucoma

Open Angle Glaucoma Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Open Angle Glaucoma market or expected to get launched during the study period. The analysis covers Open Angle Glaucoma market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Open Angle Glaucoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Discover more about therapies set to grab major Open Angle Glaucoma market share @ Open Angle Glaucoma market forecast 

Open Angle Glaucoma Therapies and Key Companies

  • PDP-716: SPARC
  • TC-002: TearClear
  • Omidenepagisopropyl/DE-117: Santen Pharmaceutical
  • DE-130A: Santen Pharmaceutical
  • Sepetaprost (DE-126/ONO9054): Santen Pharmaceutical

Open Angle Glaucoma Market Strengths

  • New drug-delivery systems offer the hope of improved therapeutic outcomes by dealing with the problem of patient compliance and therapeutic adherence
  • With the rise in awareness about the disease and its subtypes, now people are more cautious about glaucoma, its treatment and management options which will promote the glaucoma market

Scope of the Open Angle Glaucoma Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Open Angle Glaucoma Companies: Santen, Bausch and Lomb, SPARC, Nicox ophthalmics, D.Western therapeutics, and others
  • Key Open Angle Glaucoma Therapies: DP-716, TC-002, Omidenepagisopropyl/DE-117, DE-130A, Sepetaprost (DE-126/ONO9054), and others
  • Open Angle Glaucoma Therapeutic Assessment: Open Angle Glaucoma current marketed and Open Angle Glaucoma emerging therapies
  • Open Angle Glaucoma Market Dynamics:  Open Angle Glaucoma market drivers and Open Angle Glaucoma market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Open Angle Glaucoma Unmet Needs, KOL’s views, Analyst’s views, Open Angle Glaucoma Market Access and Reimbursement 

Open Angle Glaucoma Market Barriers

  • Lack of patient compliance and therapeutic adherence
  • Patients suffering from glaucoma experience poor quality of life owing to the diagnosis itself, functional visual loss, inconvenience and cost of treatment, and side effects of treatment
  • Poor socioeconomic status of the individuals leads to under diagnoses of the disease.

Table of Contents 

1. Open Angle Glaucoma Market Report Introduction

2. Executive Summary for Open Angle Glaucoma

3. SWOT analysis of Open Angle Glaucoma

4. Open Angle Glaucoma Patient Share (%) Overview at a Glance

5. Open Angle Glaucoma Market Overview at a Glance

6. Open Angle Glaucoma Disease Background and Overview

7. Open Angle Glaucoma Epidemiology and Patient Population

8. Country-Specific Patient Population of Open Angle Glaucoma 

9. Open Angle Glaucoma Current Treatment and Medical Practices

10. Open Angle Glaucoma Unmet Needs

11. Open Angle Glaucoma Emerging Therapies

12. Open Angle Glaucoma Market Outlook

13. Country-Wise Open Angle Glaucoma Market Analysis (2019–2032)

14. Open Angle Glaucoma Market Access and Reimbursement of Therapies

15. Open Angle Glaucoma Market Drivers

16. Open Angle Glaucoma Market Barriers

17.  Open Angle Glaucoma Appendix

18. Open Angle Glaucoma Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

To know more about Open Angle Glaucoma treatment, visit @  Open Angle Glaucoma Medications 

Related Reports: 

Open Angle Glaucoma Pipeline  

“Open Angle Glaucoma Pipeline Insight, 2022” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Open Angle Glaucoma market. A detailed picture of the Open Angle Glaucoma pipeline landscape is provided, which includes the disease overview and Open Angle Glaucoma treatment guidelines. 

Open Angle Glaucoma Epidemiology 

DelveInsight’s ‘Open Angle Glaucoma Epidemiology Forecast to 2032’ report delivers an in-depth understanding of the disease, historical and forecasted Open Angle Glaucoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

Latest Reports by DelveInsight

 

About DelveInsight 

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV 89107
Country: United States
Website: https://www.delveinsight.com/consulting

Categories